Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
ZhongShan Hospital Fudan University, Shanghai, Shanghai Municipality The First Affiliated Hospital, Zhejiang University School of Medicine, Hanzhou, Zhejiang